Forecasting Three-Month Outcomes in a Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR) and Atomoxetine (Strattera) in School-Aged Children With ADHD

Abstract

Objective: Compare observed and forecasted efficacy of mixed amphetamine salts extended release (MAS-XR; Adderall) with atomoxetine (Strattera) in ADHD children. Method: The authors analyze data from a randomized, double-blind, multicenter, parallel-group, forced-dose-escalation laboratory school study of children ages 6 to 12 with ADHD combined or hyperactive/impulsive type. Primary efficacy measures are attention and deportment scores on the SKAMP behavioral rating scale, and secondary efficacy measures are academic performance scores from the PERMP test. Results: MAS-XR elicits greater improvements than atomoxetine in each domain within 3 weeks of treatment, including attention, number of math problems attempted and correct, and overall clinical functioning. Treatment differences in each outcome measure at subsequent weeks are projected from generalized estimating equations to become greater with the duration of extension of the treatment regimen. Conclusion: This study suggests that relative advantages of MAS-XR seen in the first 3 weeks are likely to be maintained in subsequent weeks. (J. of Att. Dis. 2007; 11(1) 74-82)

Keywords

Adderall XR Strattera laboratory school efficacy

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (text revision). Washington, DC: Author .

Biederman, J. , Lopez, F.A. , Boellner, S.W. , & Chandler, M.C. (2002). A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit hyperactivity disorder . Pediatrics, 110, 258-266 .

Biederman, J. , Quinn, D. , Weiss, M. , Markabi, S. , Weidenman, K. , Edson, K. , et al. (2003). Efficacy and safety of Ritalin LA, a new, once-daily, extended-release dosage from of methylphenidate hydrochloride, in children with ADHD . Pediatric Drugs, 5, 833-841 .

Claxton, A.J. , Cramer, J. , & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance . Clinical Therapy , 23, 1296-1310 .

Greenhill, L.L. , Findling, R.L. , & Swanson, J.M. (2002). A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder . Pediatrics, 109, E39 .

Greenhill, L.L. , Halperin, J.M. , & Abikoff, H. (1999). Stimulant medications . Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503-512 .

Hack, S. , & Chow, B. (2001). Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance . Journal of Child and Adolescent Psychopharmacology , 11, 59-67 .

Kelsey, D.K. , Sumner, C.R. , Casat, C.D. , Coury, D.L. , Quintana, H. , Saylor, K.E. , et al. (2004). Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial . Pediatrics, 114, e1-e8 .

Michelson, D. , Allen, A.J. , Busner, J. , Casat, C. , Dunn, D. , Kratochvil, C. , et al. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized placebo-controlled study . American Journal of Psychiatry, 159, 1896-1901 .

10.

Swanson, J. (2003). Compliance with stimulants for attention-deficit/hyperactivity disorder: Issues and approaches for improvement . CNS Drugs , 17, 117-131 .

11.

Swanson, J. , Agler, D. , Fineberg, E. , Wigal, S. , Flynn, D. , Fineberg, K. , et al. (1999). UCI laboratory school protocol for PK/PD studies. In L. L. Greenhill & B. B. Osman (Eds.), Ritalin: Theory and practice (pp. 405-430). Larchmont, NY: Mary Ann Liebert .

12.

Swanson, J. , Wigal, S. , Greenhill, L. , Browne, R. , Waslick, B. , Lerner, M. , et al. (1998). Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting . Psychopharmacology Bulletin, 34, 55-60 .

13.

Wigal, S. , Gupta, S. , Guinta, D. , & Swanson, J. (1998). Reliability and validity of the SKAMP rating scale in a laboratory school setting . Psychopharmacology Bulletin , 34, 47-53 .

14.

Wigal, S.B. , Wigal, T.L. , McGough, J.J. , McCracken, J.T. , Kollins, S.H. , Biederman, J. , et al. (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/ hyperactivity disorder . Journal of Attention Disorders, 9, 275-289 .

15.

Wolraich, M. , Greenhill, L.L. , Pelham, W. , Swanson, J. , Wilens, T. , Palumbo, D. , et al. (2001). Randomized controlled trial of OROS methylphenidate qd in children with Attention Deficit/Hyperactivity Disorder . Pediatrics, 108, 883-892 .